Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?

Etienne Garin (1, 2) , Xavier Pallard (2, 1) , Julien Edeline (1, 3)

1 Foie, métabolismes et cancer
2 CRLCC - CRLCC Eugène Marquis
3 Département d'oncologie médicale [Rennes]

Correspondence. Dear Editors: It is with great interest that we read the publication written by Salem et al1: “Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.”...

Domains: Life Sciences [q-bio]; Food and Nutrition; Life Sciences [q-bio]; Cancer; Life Sciences [q-bio]; Human health and pathology; Endocrinology and metabolism

Etienne Garin, Xavier Pallard, Julien Edeline. Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?. Gastroenterology, 2017, 152 (6), pp.1624-1625. ⟨10.1053/j.gastro.2017.01.061⟩. ⟨hal-01520290⟩